UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease

The Lancet infectious diseases, 2011, Vol.11 (1), p.45-56

2011

Volltextzugriff (PDF)

Dolutegravir response in antiretroviral therapy naïve and experienced patients with M184V/I: Impact in low-and middle-income settings

International journal of infectious diseases, 2021-04, Vol.105, p.298-303

2021

Volltextzugriff (PDF)

The urgent need for more potent antiretroviral therapy in low-income countries to achieve UNAIDS 90-90-90 and complete eradication of AIDS by 2030

Infectious diseases of poverty, 2019-08, Vol.8 (1), p.63-63, Article 63

2019

Volltextzugriff (PDF)

Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism

PloS one, 2012-11, Vol.7 (11), p.e49602-e49602

2012

Volltextzugriff (PDF)

HIV-1 Resistance to Maraviroc Conferred by a CD4 Binding Site Mutation in the Envelope Glycoprotein gp120

Journal of Virology, 2013-01, Vol.87 (2), p.923-934

2013

Volltextzugriff (PDF)

Specialized DNA Structures Act as Genomic Beacons for Integration by Evolutionarily Diverse Retroviruses

Viruses, 2023-02, Vol.15 (2), p.465

2023

Volltextzugriff (PDF)

Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles

Nature communications, 2023-01, Vol.14 (1), p.16-16, Article 16

2023

Volltextzugriff (PDF)

HLA-B57/B5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition

Journal of Virology, 2009-03, Vol.83 (6), p.2743-2755

2009

Volltextzugriff (PDF)

A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2

PLoS pathogens, 2021-12, Vol.17 (12), p.e1010092-e1010092

2021

Volltextzugriff (PDF)

Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response

PLoS pathogens, 2009-04, Vol.5 (4), p.e1000365-e1000365

2009

Volltextzugriff (PDF)

A cis-Acting Element in Retroviral Genomic RNA Links Gag-Pol Ribosomal Frameshifting to Selective Viral RNA Encapsidation

Cell host & microbe, 2013-02, Vol.13 (2), p.181-192

2013

Volltextzugriff (PDF)

A Quantitative Affinity-Profiling System That Reveals Distinct CD4/CCR5 Usage Patterns among Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus Strains

Journal of Virology, 2009-11, Vol.83 (21), p.11016-11026

2009

Volltextzugriff (PDF)

Addressing an HIV cure in LMIC

Retrovirology, 2021-08, Vol.18 (1), p.21-21, Article 21

2021

Volltextzugriff (PDF)

Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses

AIDS research and therapy, 2017-09, Vol.14 (1), p.55-55, Article 55

2017

Volltextzugriff (PDF)

Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infection

PLoS pathogens, 2018-01, Vol.14 (1), p.e1006754-e1006754

2018

Volltextzugriff (PDF)

HIV-1 antiretroviral drug therapy

Cold Spring Harbor perspectives in medicine, 2012-04, Vol.2 (4), p.a007161-a007161

2012

Volltextzugriff (PDF)

Correction: A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2

PLoS pathogens, 2022-11, Vol.18 (11), p.e1011000-e1011000

2022

Volltextzugriff (PDF)

Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA

PLoS pathogens, 2011-05, Vol.7 (5), p.e1002038

2011

Volltextzugriff (PDF)

G-Quadruplex DNA and Other Non-Canonical B-Form DNA Motifs Influence Productive and Latent HIV-1 Integration and Reactivation Potential

Viruses, 2022-11, Vol.14 (11), p.2494

2022

Volltextzugriff (PDF)

Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa

EBioMedicine, 2016-11, Vol.13 (C), p.305-314

2016

Volltextzugriff (PDF)

CCR5- and CXCR4-Tropic Subtype C Human Immunodeficiency Virus Type 1 Isolates Have a Lower Level of Pathogenic Fitness than Other Dominant Group M Subtypes: Implications for the Epidemic

Journal of Virology, 2009-06, Vol.83 (11), p.5592-5605

2009

Volltextzugriff (PDF)

Effective and targeted latency reversal in CD4 + T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infection

Emerging microbes & infections, 2024-12, Vol.13 (1), p.2327371-2327371

2024

Volltextzugriff (PDF)

Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics

PLoS pathogens, 2009-04, Vol.5 (4), p.e1000377-e1000377

2009

Volltextzugriff (PDF)

The Replicative Fitness of Primary Human Immunodeficiency Virus Type 1 (HIV-1) Group M, HIV-1 Group O, and HIV-2 Isolates

Journal of Virology, 2005-07, Vol.79 (14), p.8979-8990

2005

Volltextzugriff (PDF)

Viral disinfection using nonthermal plasma: A critical review and perspectives on the plasma-catalysis system

Chemosphere (Oxford), 2022-12, Vol.309, p.136655-136655, Article 136655

2022

Volltextzugriff (PDF)

1 – 25 von 240

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(202)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Virology
(36)
Chest
(14)
Plos One
(10)
Plos Pathogens
(10)
Aids Research And Human Retroviruses
(6)
Antimicrobial Agents And Chemotherapy
(6)
Retrovirology
(6)
The Journal Of Biological Chemistry
(6)
Aids
(5)
Aids Research And Therapy
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease

Dolutegravir response in antiretroviral therapy naïve and experienced patients with M184V/I: Impact in low-and middle-income settings

The urgent need for more potent antiretroviral therapy in low-income countries to achieve UNAIDS 90-90-90 and complete eradication of AIDS by 2030

Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism

HIV-1 Resistance to Maraviroc Conferred by a CD4 Binding Site Mutation in the Envelope Glycoprotein gp120

Specialized DNA Structures Act as Genomic Beacons for Integration by Evolutionarily Diverse Retroviruses

Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles

HLA-B57/B5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition

A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2

Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response

A cis-Acting Element in Retroviral Genomic RNA Links Gag-Pol Ribosomal Frameshifting to Selective Viral RNA Encapsidation

A Quantitative Affinity-Profiling System That Reveals Distinct CD4/CCR5 Usage Patterns among Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus Strains

Addressing an HIV cure in LMIC

Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses

Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infection

HIV-1 antiretroviral drug therapy

Correction: A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2

Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA

G-Quadruplex DNA and Other Non-Canonical B-Form DNA Motifs Influence Productive and Latent HIV-1 Integration and Reactivation Potential

Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa

CCR5- and CXCR4-Tropic Subtype C Human Immunodeficiency Virus Type 1 Isolates Have a Lower Level of Pathogenic Fitness than Other Dominant Group M Subtypes: Implications for the Epidemic

Effective and targeted latency reversal in CD4 + T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infection

Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics

The Replicative Fitness of Primary Human Immunodeficiency Virus Type 1 (HIV-1) Group M, HIV-1 Group O, and HIV-2 Isolates

Viral disinfection using nonthermal plasma: A critical review and perspectives on the plasma-catalysis system

Suchergebnisse filtern